IDWeek 2020: Physicians Taking a Hit in the Wallet by COVID-19
To evaluate the impacts of COVID-19—such as job loss, increased work hours, and the compensation...
Read MoreOct 30, 2020
To evaluate the impacts of COVID-19—such as job loss, increased work hours, and the compensation...
Read MoreOct 30, 2020
Although evidence indicates that undiagnosed cases of HIV are often found during routine screening...
Read MoreOct 30, 2020
Anthony Fauci, MD, said during a presentation at IDWeek that he is “cautiously optimistic” that a...
Read MoreOct 30, 2020
In 2018, University of Kentucky (UK) HealthCare reported 400 cases of endocarditis, of which 73%...
Read MoreOct 30, 2020
Lucy S. Tompkins, MD, PhD, reported zero blood culture contamination events (0.0% contamination...
Read MoreOct 30, 2020
The best strategy for addressing extreme violence, including a shooter, in the ED is preparation...
Read MoreOct 30, 2020
In a presentation from Lauren Westafer, DO, MPH, MS, advised emergency physicians to not treat...
Read MoreOct 30, 2020
ACR Convergence 2020, the world’s premier virtual rheumatology experience, is happening online, November 5 – 9. The fully virtual meeting is where rheumatology can collaborate, celebrate, innovate, and learn. During ACR...
Read MoreOct 30, 2020
Recent estimates suggest 60,000 or Los Angeles’s 4 million residents are homeless, including a...
Read MoreOct 30, 2020
Research indicates that trauma among patients on anti-factor Xa drugs can produce life-threatening...
Read MoreOct 30, 2020
A joint poll from ACEP and Morning Consult was conducted between October 7-October 13, 2020 among...
Read MoreOct 30, 2020
In arthritis and other autoimmune disorders, chronic inflammation is mediated primarily by pro-inflammatory reactive macrophages. Systemic administration of anti-inflammatory agents does not selectively target the affected...
Read MoreOct 30, 2020
New data from the global Phase 2 clinical trial of mavrilimumab in giant cell arteritis (GCA) will be presented at the late-breaking abstracts session during the American College of Rheumatology (ACR) Convergence 2020....
Read MoreOct 30, 2020
A body of research will be presented at this year’s ACR meeting in the hopes of demonstrating the potential for upadacitinib and adalimumab to play a significant role in the treatment of rheumatic diseases. Data evaluating...
Read MoreOct 30, 2020
Achievement of RAPID3 and cDAPSA Treatment Targets Is Associated with Control of Articular and Extra-Articular Manifestations of Active Psoriatic Arthritis in DMARD-Naive Patients Treated with Apremilast...
Read MoreOct 30, 2020
The study was done to identify dysregulated metabolic pathways in ALS versus control participants...
Read MoreOct 30, 2020
This study was done to compare social cognition performance between patients with ALS and patients...
Read MoreOct 30, 2020
The study was done to check the efficacy and safety of bilateral GPi-DBS in refractory MS and...
Read MoreOct 30, 2020
OCD is a major cause of disability and impairment of quality of life. 10% of patients are reported...
Read MoreOct 30, 2020
Approximately 15%–20% of patients with GBS are unable to walk independently at 6 months from the...
Read More